Anbio Biotechnology Class A(NNNN)
$3.80-0.28 (-2.31%)
NNNN
Anbio Biotechnology Class A Revenue
$3.80
At close:-0.28 (-2.31%)
Anbio Biotechnology Class A (NNNN) Revenue
62 Followers
Anbio Biotechnology Class A Revenue
Anbio Biotechnology Class A had a revenue of 4.74M in the quarter ending Dec 31, 2025, with 133.25%. This bring the company's revenue in the last twelve months to 8.65M, Increased 34.32%. In the fiscal year ending Dec 31, 2025, Anbio Biotechnology Class A had annual revenue of 8.65M with 5.64% growth.
- Revenue (ttm)
- 8.65M
- Revenue Growth
- 10.10%
- P/S Ratio
- 63.24
- Revenue/Employee
- $320,253
- Employees
- 27
- Market Cap
- $546.79M
Revenue Chart
Anbio Biotechnology Class A Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.65M | 461.70K | 5.64% |
| Dec 31, 2024 | 8.19M | 1.47M | 21.95% |
| Dec 31, 2023 | 6.71M | -16.83M | -71.49% |
| Dec 31, 2022 | 23.54M | 19.12M | 431.67% |
| Dec 31, 2021 | 4.43M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.